{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:02:21Z","timestamp":1781128941083,"version":"3.54.1"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8683-16","type":"journal-article","created":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T22:08:09Z","timestamp":1506290889000},"page":"2943-2948","source":"Crossref","is-referenced-by-count":7,"title":["Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis"],"prefix":"10.2169","volume":"56","author":[{"given":"Keiji","family":"Ohashi","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ei","family":"Sada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Katsuyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshia","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Katsuyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Narazaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Tatebe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsue","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dutta P, Hayatbhat M, Bhansali A, Bambery P, Kakar N. Wegener's granulomatosis presenting as diabetes insipidus. Exp Clin Endocrinol Diabetes 114: 533-536, 2006.","DOI":"10.1055\/s-2006-924122"},{"key":"2","unstructured":"2. Yokoseki A, Saji E, Arakawa M, et al. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain 137: 520-536, 2014."},{"key":"3","unstructured":"3. Harabuchi Y, Kishibe K, Tateyama K, et al. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan. Mod Rheumatol 27: 87-94, 2017."},{"key":"4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1212\/WNL.52.2.420","volume":"52","author":"JY Li","year":"1999","unstructured":"4. Li JY, Lai PH, Lam HC, et al. Hypertrophic cranial pachymeningitis and lymphocytic hypophysitis in Sj\u00f6gren's syndrome. Neurology 52: 420-423, 1999.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Hatano N, Behari S, Nagatani T, et al. Idiopathic hypertrophic cranial pachymeningitis: clinicoradiological spectrum and therapeutic options. Neurosurgery 45: 1336-1342; discussion 1342-1334, 1999.","DOI":"10.1097\/00006123-199912000-00014"},{"key":"6","unstructured":"6. De Luna G, Terrier B, Kaminsky P, et al. Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes. Rheumatology (Oxford) 54: 424-432, 2015."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L. Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85: 54-65, 2006.","DOI":"10.1097\/01.md.0000200166.90373.41"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yates M, Watts RA, Bajema IM, et al. EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75: 1583-1594, 2016.","DOI":"10.1136\/annrheumdis-2016-209133"},{"key":"9","unstructured":"9. Di Comite G, Bozzolo EP, Praderio L, Tresoldi M, Sabbadini MG. Meningeal involvement in Wegener's granulomatosis is associated with localized disease. Clin Exp Rheumatol 24: S60-S64, 2006."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yonekawa T, Murai H, Utsuki S, et al. A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry 85: 732-739, 2014.","DOI":"10.1136\/jnnp-2013-306410"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sada KE, Yamamura M, Harigai M, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 16: R101, 2014.","DOI":"10.1186\/ar4550"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tappouni R, Burns A. Pituitary involvement in Wegener's granulomatosis. Nephrol Dial Transplant 15: 2057-2058, 2000.","DOI":"10.1093\/ndt\/15.12.2057"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Garovic VD, Clarke BL, Chilson TS, Specks U. Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener's granulomatosis. Am J Kidney Dis 37: E5, 2001.","DOI":"10.1016\/S0272-6386(01)90002-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Barlas NB, Hassan HH, Al Badr FB, Bilal A. Structural and functional involvement of pituitary gland in Wegener's granulomatosis. Clin Neuroradiol 21: 31-33, 2011.","DOI":"10.1007\/s00062-010-0037-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Xue J, Wang H, Wu H, Jin Q. Wegener's granulomatosis complicated by central diabetes insipidus and peripheral neutrophy with normal pituitary in a patient. Rheumatol Int 29: 1213-1217, 2009.","DOI":"10.1007\/s00296-008-0774-6"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Yong TY, Li JY, Amato L, et al. Pituitary involvement in Wegener's granulomatosis. Pituitary 11: 77-84, 2008.","DOI":"10.1007\/s11102-007-0021-2"},{"key":"17","unstructured":"17. Thiryayi W, Donaldson MH, Border D, Tyagi A. An enhancing pituitary lesion in a young woman: a diagnostic dilemma. J Clin Neurosci 14: 286-288, 2007."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Duzgun N, Morris Y, Gullu S, et al. Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener's granulomatosis. Rheumatol Int 26: 80-82, 2005.","DOI":"10.1007\/s00296-005-0583-0"},{"key":"19","unstructured":"19. Goyal M, Kucharczyk W, Keystone E. Granulomatous hypophysitis due to Wegener's granulomatosis. AJNR Am J Neuroradiol 21: 1466-1469, 2000."},{"key":"20","unstructured":"20. Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ. Pituitary involvement by Wegener's granulomatosis: a report of two cases. AJNR Am J Neuroradiol 20: 519-523, 1999."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Santoro SG, Guida AH, Furioso AE, Glikman P, Rogozinski AS. Panhypopituitarism due to Wegener's granulomatosis. Arq Bras Endocrinol Metabol 55: 481-485, 2011.","DOI":"10.1590\/S0004-27302011000700008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cunnington JR, Jois R, Zammit I, Scott D, Isaacs J. Diabetes insipidus as a complication of Wegener's granulomatosis and its treatment with biologic agents. Int J Rheumatol 2009: 346136, 2009.","DOI":"10.1155\/2009\/346136"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. McIntyre EA, Perros P. Fatal inflammatory hypophysitis. Pituitary 10: 107-111, 2007.","DOI":"10.1007\/s11102-007-0016-z"},{"key":"24","unstructured":"24. Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D. Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience. J Clin Endocrinol Metab 99: 3988-3994, 2014."},{"key":"25","unstructured":"25. De Parisot A, Pu\u00e9chal X, Langrand C, et al. Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. Medicine (Baltimore) 94: e748, 2015."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352: 351-361, 2005.","DOI":"10.1056\/NEJMoa041884"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/21\/56_8683-16\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T22:32:09Z","timestamp":1570141929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/21\/56_8683-16\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":26,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8683-16","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}